The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Open accessAbstract
Macrophages perform both injury-inducing and repair-promoting tasks in different models of inflammation, leading to a model of macrophage function in which distinct patterns of activation have been proposed. We investigated macrophage function mechanistically in a reversible model of liver injury in which the injury and recovery phases are distinct. Carbon tetrachloride---induced liver fibrosis revealed scar-associated macrophages that persisted throughout recovery. A transgenic mouse (CD11b-DTR) was generated in which macrophages could be selectively depleted. Macrophage depletion when liver fibrosis was advanced resulted in reduced scarring and fewer myofibroblasts. Macrophage depletion during recovery, by contrast, led to a failure of matrix degradation. These data provide the first clear evidence that functionally distinct subpopulations of macrophages exist in the same tissue and that these macrophages play critical roles in both the injury and recovery phases of inflammatory scarring.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Self-citationMurphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111490200 · Cited by 432
Self-citation
Research works printed but not linked: 45
- Leibovich, 1975, Am. J. Pathol., 78, 71
- Kodelja, 1997, Immunobiology., 197, 478, 10.1016/S0171-2985(97)80080-0 · DOI
- 10.1161/01.CIR.0000023532.98469.48 · DOI
- 10.1046/j.1365-2567.2000.00143.x · DOI
- 10.1038/334260a0 · DOI
- Diez-Roux, 1997, Development., 124, 3633, 10.1242/dev.124.18.3633 · DOI
- 10.1097/01.LAB.0000101911.53973.90 · DOI
- 10.1042/CS20020240 · DOI
- 10.1016/S1074-7613(00)80014-X · DOI
- Mariani, 1998, Mol. Biol. Cell., 9, 1411, 10.1091/mbc.9.6.1411 · DOI
- 10.1006/cimm.2000.1687 · DOI · Paper page
- Buechler, 2000, J. Leukoc. Biol., 67, 97, 10.1002/jlb.67.1.97 · DOI
- Willment, 2003, J. Immunol., 171, 4569, 10.4049/jimmunol.171.9.4569 · DOI
- Zhang, 1998, J. Immunol., 161, 3071, 10.4049/jimmunol.161.6.3071 · DOI
- 10.1172/JCI118620 · DOI
- Erwig, 1998, J. Immunol., 161, 1983, 10.4049/jimmunol.161.4.1983 · DOI
- 10.1016/S1471-4906(02)02302-5 · DOI · Paper page
- 10.1080/1044667031000137629 · DOI
- 10.1038/ki.1991.284 · DOI
- Duffield, 2001, Am. J. Pathol., 159, 1397, 10.1016/S0002-9440(10)62526-6 · DOI
- 10.1053/j.gastro.2004.03.009 · DOI
- 10.1016/S1074-7613(02)00365-5 · DOI
- 10.1038/90795 · DOI
- 10.1016/0092-8674(92)90623-K · DOI
- Dziennis, 1995, Blood., 85, 319, 10.1182/blood.V85.2.319.319 · DOI
- 10.1007/BF01002772 · DOI
- 10.1161/01.CIR.0000038109.84500.1E · DOI
- 10.1002/hep.510300236 · DOI
- 10.1055/s-2001-17557 · DOI
- Issa, 2003, FASEB J., 17, 47, 10.1096/fj.02-0494fje · DOI
- 10.1053/j.gastro.2004.02.025 · DOI
- Stuart, 2002, J. Immunol., 168, 1627, 10.4049/jimmunol.168.4.1627 · DOI
- McDonald, 1999, J. Immunol., 163, 6164, 10.4049/jimmunol.163.11.6164 · DOI
- Morath, 2001, J. Am. Soc. Nephrol., 12, 2300, 10.1681/ASN.V12112300 · DOI
- 10.1097/01.TP.0000083507.67995.13 · DOI
- Westerhuis, 2000, Am. J. Pathol., 156, 303, 10.1016/S0002-9440(10)64731-1 · DOI
- Feith, 1997, Exp. Nephrol., 5, 301
- 10.1002/hep.510230544 · DOI
- Diez-Roux, 1999, Development., 126, 2141, 10.1242/dev.126.10.2141 · DOI
- 10.1073/pnas.88.6.2065 · DOI
- 10.1172/JCI117565 · DOI
- Morris, 1991, Development., 112, 517, 10.1242/dev.112.2.517 · DOI
- 10.1046/j.1523-1755.1999.00580.x · DOI
- Hughes, 1999, Am. J. Physiol., 277, F26
- Stahelin, 1998, Mol. Pathol., 51, 204, 10.1136/mp.51.4.204 · DOI
Cited by
Sorted by citations
Items 101–170 of 170
Principles of Cell Circuits for Tissue Repair and Fibrosis
Adler, M., Mayo, A., Zhou, X., Franklin, R. A., Meizlish, M. L., Medzhitov, R., Kallenberger, S. M., & Alon, U. (2020) · iScience · doi:10.1016/j.isci.2020.100841 · Cited by 177
Li, X., Jin, Q., Yao, Q., Xu, B., Li, L., Zhang, S., & Tu, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00072 · Cited by 171
Bird, T. G., Lu, W.-Y., Boulter, L., Gordon-Keylock, S., Ridgway, R. A., Williams, M. J., Taube, J., Thomas, J. A., Wojtacha, D., Gambardella, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302168110 · Cited by 166
Self-citationPathophysiology of NASH: perspectives for a targeted treatment
Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990344 · Cited by 163
Inflammatory manifestations of lymphedema
Ly, C., Kataru, R., & Mehrara, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010171 · Cited by 164
Watanabe, Y., Tsuchiya, A., Seino, S., Kawata, Y., Kojima, Y., Ikarashi, S., Starkey Lewis, P. J., Lu, W.-Y., Kikuta, J., Kawai, H., et al. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0105 · Cited by 155
Self-citationToll-like Receptor 4 and Hepatic Fibrogenesis
Pradere, J.-P., Troeger, J., Dapito, D., Mencin, A., & Schwabe, R. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255353 · Cited by 158
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
Meier, R. P. H., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., Christofilopoulos, P., Wandrey, C., Gonelle-Gispert, C., & Bühler, L. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.030 · Cited by 153
Dendritic Cell Regulation of Carbon Tetrachloride–Induced Murine Liver Fibrosis Regression
Jiao, J., Sastre, D., Fiel, M. I., Lee, U. E., Ghiassi–Nejad, Z., Ginhoux, F., Vivier, E., Friedman, S. L., Merad, M., & Aloman, C. (2012) · Hepatology · doi:10.1002/hep.24621 · Cited by 154
Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2
Lan, T., Li, C., Yang, G., Sun, Y., Zhuang, L., Ou, Y., Li, H., Wang, G., Kisseleva, T., Brenner, D., et al. (2018) · Hepatology · doi:10.1002/hep.29885 · Cited by 153
Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2
Ganguly, S., Rosenthal, S. B., Ishizuka, K., Troutman, T. D., Rohm, T. V., Khader, N., Aleman-Muench, G., Sano, Y., Archilei, S., Soroosh, P., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2405746121 · Cited by 145
Pulli, B., Ali, M., Iwamoto, Y., Zeller, M. W. G., Schob, S., Linnoila, J. J., & Chen, J. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6108 · Cited by 143
Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis
Borthwick, L. A., Barron, L., Hart, K. M., Vannella, K. M., Thompson, R. W., Oland, S., Cheever, A., Sciurba, J., Ramalingam, T. R., Fisher, A. J., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.34 · Cited by 138
The therapeutic potential of galectin-3 inhibition in fibrotic disease
Slack, R. J., Mills, R., & Mackinnon, A. C. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105881 · Cited by 136
Reversibility of liver fibrosis
Pellicoro, A., Ramachandran, P., & Iredale, J. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s26 · Cited by 135
Self-citationBeaven, S. W., Wroblewski, K., Wang, J., Hong, C., Bensinger, S., Tsukamoto, H., & Tontonoz, P. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.053 · Cited by 131
The brain’s best friend: microglial neurotoxicity revisited
Hellwig, S., Heinrich, A., & Biber, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00071 · Cited by 126
Wang, Y., Wang, J., Zhang, J., Wang, Y., Wang, Y., Kang, H., Zhao, W., Bai, W., Miao, N., & Wang, J. (2024) · Science Advances · doi:10.1126/sciadv.adj3289 · Cited by 131
Rantakari, P., Patten, D. A., Valtonen, J., Karikoski, M., Gerke, H., Dawes, H., Laurila, J., Ohlmeier, S., Elima, K., Hübscher, S. G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604780113 · Cited by 119
How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P. (2015) · BioMed Research International · doi:10.1155/2015/984578 · Cited by 120
Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis
Bellón, T., Martínez, V., Lucendo, B., del Peso, G., Castro, M. J., Aroeira, L. S., Rodríguez-Sanz, A., Ossorio, M., Sánchez-Villanueva, R., Selgas, R., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq771 · Cited by 114
Macrophages: Central regulators of hepatic fibrogenesis and fibrosis resolution
Ramachandran, P., & Iredale, J. P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.026 · Cited by 113
Self-citationMechanosensing regulates tissue repair program in macrophages
Meizlish, M. L., Kimura, Y., Pope, S. D., Matta, R., Kim, C., Philip, N. H., Meyaard, L., Gonzalez, A., & Medzhitov, R. (2024) · Science Advances · doi:10.1126/sciadv.adk6906 · Cited by 114
Temporally distinct myeloid cell responses mediate damage and repair after cerebrovascular injury
Mastorakos, P., Mihelson, N., Luby, M., Burks, S. R., Johnson, K., Hsia, A. W., Witko, J., Frank, J. A., Latour, L., & McGavern, D. B. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00773-6 · Cited by 113
Functional role of chemokines in liver disease models
Sahin, H., Trautwein, C., & Wasmuth, H. E. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.168 · Cited by 107
Bansal, R., van Baarlen, J., Storm, G., & Prakash, J. (2015) · Scientific Reports · doi:10.1038/srep18272 · Cited by 107
MMP-10 Regulates Collagenolytic Activity of Alternatively Activated Resident Macrophages
Rohani, M. G., McMahan, R. S., Razumova, M. V., Hertz, A. L., Cieslewicz, M., Pun, S. H., Regnier, M., Wang, Y., Birkland, T. P., & Parks, W. C. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.167 · Cited by 101
Kono, H., Karmarkar, D., Iwakura, Y., & Rock, K. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902485 · Cited by 101
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Cao, Y., Ji, C., & Lu, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.119 · Cited by 99
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
Habib, A., Chokr, D., Wan, J., Hegde, P., Mabire, M., Siebert, M., Ribeiro-Parenti, L., Le Gall, M., Lettéron, P., Pilard, N., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316137 · Cited by 91
Wagner, M., Bjerkvig, R., Wiig, H., Melero-Martin, J. M., Lin, R.-Z., Klagsbrun, M., & Dudley, A. C. (2012) · Angiogenesis · doi:10.1007/s10456-012-9276-y · Cited by 91
Protective features of peripheral monocytes/macrophages in stroke
Gliem, M., Schwaninger, M., & Jander, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.004 · Cited by 88
Neutrophils alleviate fibrosis in the CCl4-induced mouse chronic liver injury model
Saijou, E., Enomoto, Y., Matsuda, M., Yuet‐Yin Kok, C., Akira, S., Tanaka, M., & Miyajima, A. (2018) · Hepatology Communications · doi:10.1002/hep4.1178 · Cited by 84
Ezzo, M., Spindler, K., Wang, J. B., Lee, D., Pecoraro, G., Cowen, J., Pakshir, P., & Hinz, B. (2024) · Science Advances · doi:10.1126/sciadv.adp4726 · Cited by 82
Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology
Chang, M.-L., & Yang, S.-S. (2019) · Cells · doi:10.3390/cells8111423 · Cited by 81
Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice
Luo, S., Zhao, X., Jiang, J., Deng, B., Liu, S., Xu, H., Tan, Q., Chen, Y., Zhang, Z., Pan, X., et al. (2023) · Theranostics · doi:10.7150/thno.86103 · Cited by 76
Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
Somnay, K., Wadgaonkar, P., Sridhar, N., Roshni, P., Rao, N., & Wadgaonkar, R. (2024) · Biomedicines · doi:10.3390/biomedicines12102229 · Cited by 70
The immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
Xu, Y., Ying, L., Lang, J. K., Hinz, B., & Zhao, R. (2024) · Science Advances · doi:10.1126/sciadv.adj9559 · Cited by 67
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03406-8 · Cited by 66
Self-citationThe Origin and Fate of Liver Myofibroblasts
Kim, H. Y., Sakane, S., Eguileor, A., Carvalho Gontijo Weber, R., Lee, W., Liu, X., Lam, K., Ishizuka, K., Rosenthal, S. B., Diggle, K., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.008 · Cited by 63
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
Binatti, E., Gerussi, A., Barisani, D., & Invernizzi, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126649 · Cited by 62
Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation
Tadokoro, T., Murata, S., Kato, M., Ueno, Y., Tsuchida, T., Okumura, A., Kuse, Y., Konno, T., Uchida, Y., Yamakawa, Y., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg0338 · Cited by 58
Activated Hepatic Stellate Cells Mediate the Differentiation of Macrophages
Chang, J., Hisamatsu, T., Shimamura, K., Yoneno, K., Adachi, M., Naruse, H., Igarashi, T., Higuchi, H., Matsuoka, K., Kitazume, M. T., et al. (2013) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01111.x · Cited by 56
Targeting the stromal microenvironment in chronic inflammation
FILER, A., PITZALIS, C., & BUCKLEY, C. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.007 · Cited by 45
Ryan, A. J., Larson-Casey, J. L., He, C., Murthy, S., & Carter, A. B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.579870 · Cited by 43
Glucocorticoids have opposing effects on liver fibrosis in hepatic stellate and immune cells
Kim, K. H., Lee, J. M., Zhou, Y., Harpavat, S., & Moore, D. D. (2016) · Molecular Endocrinology · doi:10.1210/me.2016-1029 · Cited by 41
Su, S.-B., Qin, S.-Y., Xian, X.-L., Huang, F.-F., Huang, Q.-L., ZhangDi, H.-J., & Jiang, H.-X. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118677 · Cited by 40
Manco, R., Leclercq, I. A., & Clerbaux, L.-A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124115 · Cited by 36
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis
Mooring, M., Yeung, G. A., Luukkonen, P., Liu, S., Akbar, M. W., Zhang, G. J., Balogun, O., Yu, X., Mo, R., Nejak-Bowen, K., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade3157 · Cited by 33
Uhlig, M., Billig, S., Wienhold, J., & Schumacher, D. (2025) · Cells · doi:10.3390/cells14050345 · Cited by 29
Mechanisms of liver fibrosis in metabolic syndrome
Mehal, W. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100015 · Cited by 28
Kim, K., Cheng, N., & Lau, L. F. (2022) · Hepatology Communications · doi:10.1002/hep4.2057 · Cited by 26
“These findings provide molecular details to the observations that macrophages are profibrotic in the early phase of injury response and that macrophage engulfment of apoptotic bodies promotes the expression of profibrotic cytokines.[8,34] CCN1 is quickly released from platelet α- granules following tissue damage.”
BackgroundIwata, A., Maruyama, J., Natsuki, S., Nishiyama, A., Tamura, T., Tanaka, M., Shichino, S., Seki, T., Komai, T., Okamura, T., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06357-5 · Cited by 25
Mortality from cirrhosis: lack of progress over the last 35 years
Gluud, C. (2005) · Gut · doi:10.1136/gut.2005.072876 · Cited by 17
Kawao, N., Nagai, N., Tamura, Y., Okada, K., Yano, M., Suzuki, Y., Umemura, K., Ueshima, S., & Matsuo, O. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-08-0516 · Cited by 17
Beyond M1/M2: The role of reactive oxygen species in liver fibrosis and immune modulation
Lu, H., Huang, J., Wang, Y.-C., Casals, E., Casals, G., & Zeng, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103933 · Cited by 19
Future mechanistic strategies for tackling fibrosis–an unmet need in liver disease
Fallowfield, J. A. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s83 · Cited by 15
Protozoan‐Derived Cytokine‐Transgenic Macrophages Reverse Hepatic Fibrosis
Chen, Y., Wang, J., Zhou, N., Fang, Q., Cai, H., Du, Z., An, R., Liu, D., Chen, X., Wang, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202308750 · Cited by 12
Effect of different types of macrophages on hepatic fibrosis in Echinococcus Granulosus mice
Li, B., Liu, Y.-M., Yan, Y., Yang, N., Gao, J., Jiang, T., Shang, X.-Q., Tian, F.-M., Ding, J.-B., & Ma, X.-M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109178 · Cited by 11
Krishnan, A., Ozturk, N. B., Cutshaw, K. A., Guicciardi, M. E., Kitagataya, T., Olson, K. E., Pavelko, K. D., Sherman, W., Wixom, A. Q., Jalan-Sakrikar, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52710-3 · Cited by 8
Macrophage heterogeneity in liver fibrosis
Wang, W., Li, S., Liu, Y., Ding, X., Yang, Y., Chen, S., Cao, J., Tacke, F., Dong, W., & Lan, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1639455 · Cited by 8
M. S. Barron, A., Fabre, T., & De, S. (2024) · F1000Research · doi:10.12688/f1000research.143472.1 · Cited by 8
Modulation of inflammatory M1-macrophages phenotype by valvular interstitial cells
Tagzirt, M., Rosa, M., Corseaux, D., Vincent, F., Vincentelli, A., Daoudi, M., Jashari, R., Staels, B., Van Belle, E., Susen, S., et al. (2023) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2022.08.027 · Cited by 6
Astrab, L. R., Skelton, M. L., & Caliari, S. R. (2024) · doi:10.1101/2024.10.13.618034 · Cited by 2
Targeting macrophages in liver fibrosis
González del Barrio, L., Ipsen, D. H., Pfister, D. R., Hancz, D., & Scott, C. L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835489 · Cited by 3
Metadata
- Authors
- Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P.
- Affiliations
- Brigham and Women's Hospital (US)
- St Mary's Hospital (GB)
- University of Southampton (GB)
- Centre for Inflammation Research (GB)
- New York University (US)
- Regeneron (United States) (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Duffield, Jeremy S.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-01-03
- Volume
- 115
- Issue
- 1
- Pages
- 56-65
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC539199
- OpenAlex
- W4250007760
- Cited by
- 1,649
- References
- 3
- Citations by year
- 2026: 40 · 2025: 58 · 2024: 84 · 2023: 66 · 2022: 79 · 2021: 97 · 2020: 81 · 2019: 96 · 2018: 87 · 2017: 90 · 2016: 100 · 2015: 98 · 2014: 95 · 2013: 92 · 2012: 100
- FWCI
- 39.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Children's Liver Disease Foundation
- Imperial College London
- Wessex Medical Research
- Medical Research Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- macrophages, liver fibrosis, myofibroblasts, extracellular matrix degradation, macrophage heterogeneity, carbon tetrachloride
- MeSH terms
- Animals, Carbon Tetrachloride, Diphtheria Toxin, Extracellular Matrix, Female, Gene Expression Regulation, Liver, Liver Cirrhosis, Macrophages, Mice, Transgenic, Models, Biological, Wound Healing, Cytokines, Gene Deletion, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review